Clario Improves Patient Compliance in Cardiac Studies with Home Blood Pressure ServiceJune 14, 2021
Remote blood pressure monitoring service standardizes BP collection
PHILADELPHIA – June 10, 2021 – ERT, the global leader in clinical endpoint data collection, today announced the expansion of its clinical trial endpoint data collection portfolio with at-home blood pressure (BP) monitoring solution. This completes a suite of blood pressure assessment services developed by ERT that allow for greater flexibility in collecting patients’ blood pressure in traditional, hybrid, and decentralized trial environments.
“High quality blood pressure data is critical evidence in many types of clinical trials, and our customers rely on us to provide the innovations that deliver it, whether the assessment is conducted in-clinic or remotely,” said Ellen Street, Product Line Executive of Cardiac Safety Solutions at ERT. “By offering blood pressure collection at home, we increase patient compliance and the frequency of data collection for better safety assessment.”
ERT’s specialized software secures BP data capture, ensuring higher quality data for confident decision making than other self-reported home blood pressure collection options. ERT’s easy-to-use monitor and tailored application with built-in workflow ensure the patient follows instructions for accurate data collection from their home, then sends real-time patient data for immediate investigator review.
“In the traditional setting of a physician’s office, blood pressure collection can be influenced by a ‘white coat effect’ in which a patient’s reaction to the visit causes a rise in blood pressure,” stated Street. “This is another one of the reasons we recommend home blood pressure monitoring in addition to in-clinic. It can actually yield more accurate data.
ERT is the market leader in cardiac safety solutions, providing clinically validated solutions and the experience and expertise to support cardiac safety needs for all phases of clinical trials. As ERT merges with BioClinica, the joint company’s combined industry expertise and market leadership will drive its commitment to provide complete solutions to enable high quality, clinical-grade endpoint data collection in traditional, hybrid, and decentralized clinical trials.
Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.